It has been reported that the common glucose transporter in humans, GLUT1, is overexpressed in malignancies including hepatic, pancreatic, breast, brain, renal, lung, colorectal, ovarian, and cervical cancers (Yu et al. 2017). Here, SLC2A1 is linked to cervical carcinoma.